Cargando…
Randomizing a clinical trial in neuro-degenerative disease
The paper studies randomization rules for a sequential two-treatment, two-site clinical trial in Parkinson’s disease. An important feature is that we have values of responses and five potential prognostic factors from a sample of 144 patients similar to those to be enrolled in the trial. Analysis of...
Autores principales: | Atkinson, Anthony C., Duarte, Belmiro P.M., Pedrosa, David J., van Munster, Marlena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10172741/ https://www.ncbi.nlm.nih.gov/pubmed/37180844 http://dx.doi.org/10.1016/j.conctc.2023.101140 |
Ejemplares similares
-
Safety perception in patients with advanced idiopathic Parkinson’s disease – a qualitative study
por: Pedrosa, Anna J., et al.
Publicado: (2023) -
Measuring Quality of Life in Parkinson’s Disease—A Call to Rethink Conceptualizations and Assessments
por: Stührenberg, Maria, et al.
Publicado: (2022) -
Involvement of an Aberrant Vascular System in Neurodevelopmental, Neuropsychiatric, and Neuro-Degenerative Diseases
por: Ishihara, Keiichi, et al.
Publicado: (2023) -
Editorial: Neuropharmacology of neuro -degenerative, -logical, -psychiatric disorders
por: Kaur, Harpreet
Publicado: (2023) -
Coping Styles in Patients with Parkinson’s Disease: Consideration in the Co-Designing of Integrated Care Concepts
por: Stümpel, Johanne, et al.
Publicado: (2022)